Literature DB >> 27201937

The Use and Acceptance of Novel Statistical Analyses To Support Technology Submissions To Hta Authorities.

S Batson1, S A Mitchell1, D King1.   

Abstract

Entities:  

Year:  2014        PMID： 27201937     DOI： 10.1016/j.jval.2014.08.1943

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

Review 1.  Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence.

Authors:  Alexis Llewellyn; Rita Faria; Beth Woods; Mark Simmonds; James Lomas; Nerys Woolacott; Susan Griffin
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.